Silicon Valley Investor Ups Biotech Startup’s Latest Funding Round to $57 Million

“Galera Therapeutics, a biotech startup born out of research in Dennis Riley’s lab at Monsanto Co., has added $15 million to its latest funding round, bringing the raise to $57 million overall.

The new money comes from Sofinnova Ventures, a Silicon Valley-based clinical-stage biopharmaceutical venture capital firm with approximately $2.2 billion under management.”

Read the full Business Journal article here.